Clinical Trials
3 trialsNCT07614282 2026-05-29
Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia
Columbia University
Phase 1 Not yet recruiting
NCT04364178 2026-05-27
Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV
Stanford University
Phase 1/2 Terminated
NCT02135042 2026-05-07
Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting